Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer.

Watt MJ, Clark AK, Selth LA, Haynes VR, Lister N, Rebello R, Porter LH, Niranjan B, Whitby ST, Lo J, Huang C, Schittenhelm RB, Anderson KE, Furic L, Wijayaratne PR, Matzaris M, Montgomery MK, Papargiris M, Norden S, Febbraio M, Risbridger GP, Frydenberg M, Nomura DK, Taylor RA.

Sci Transl Med. 2019 Feb 6;11(478). pii: eaau5758. doi: 10.1126/scitranslmed.aau5758.

PMID:
30728288
2.

Tissue engineered human prostate microtissues reveal key role of mast cell-derived tryptase in potentiating cancer-associated fibroblast (CAF)-induced morphometric transition in vitro.

Pereira BA, Lister NL, Hashimoto K, Teng L, Flandes-Iparraguirre M, Eder A, Sanchez-Herrero A, Niranjan B; Melbourne Urological Research Alliance (MURAL).

Biomaterials. 2019 Mar;197:72-85. doi: 10.1016/j.biomaterials.2018.12.030. Epub 2019 Jan 2.

PMID:
30641266
3.

Evaluation of Changes in Salivary pH after Intake of Different Eatables and Beverages in Children at Different Time Intervals.

Pachori A, Kambalimath H, Maran S, Niranjan B, Bhambhani G, Malhotra G.

Int J Clin Pediatr Dent. 2018 May-Jun;11(3):177-182. doi: 10.5005/jp-journals-10005-1507. Epub 2018 Jun 1.

4.

Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy.

Lawrence MG, Obinata D, Sandhu S, Selth LA, Wong SQ, Porter LH, Lister N, Pook D, Pezaro CJ, Goode DL, Rebello RJ, Clark AK, Papargiris M, Van Gramberg J, Hanson AR, Banks P, Wang H, Niranjan B, Keerthikumar S, Hedwards S, Huglo A, Yang R, Henzler C, Li Y, Lopez-Campos F, Castro E, Toivanen R, Azad A, Bolton D, Goad J, Grummet J, Harewood L, Kourambas J, Lawrentschuk N, Moon D, Murphy DG, Sengupta S, Snow R, Thorne H, Mitchell C, Pedersen J, Clouston D, Norden S, Ryan A, Dehm SM, Tilley WD, Pearson RB, Hannan RD, Frydenberg M, Furic L, Taylor RA, Risbridger GP.

Eur Urol. 2018 Nov;74(5):562-572. doi: 10.1016/j.eururo.2018.06.020. Epub 2018 Jul 23.

PMID:
30049486
5.

Enduring epigenetic landmarks define the cancer microenvironment.

Pidsley R, Lawrence MG, Zotenko E, Niranjan B, Statham A, Song J, Chabanon RM, Qu W, Wang H, Richards M, Nair SS, Armstrong NJ, Nim HT, Papargiris M, Balanathan P, French H, Peters T, Norden S, Ryan A, Pedersen J, Kench J, Daly RJ, Horvath LG, Stricker P, Frydenberg M, Taylor RA, Stirzaker C, Risbridger GP, Clark SJ.

Genome Res. 2018 May;28(5):625-638. doi: 10.1101/gr.229070.117. Epub 2018 Apr 12.

6.

Prevalence of Dental Caries and Traumatic Dental Injuries among 6- to 12-year-old Children in Bhopal City, India.

Maran S, Shashikiran ND, Ahirwar P, Maran P, Raj Kannojiya P, Niranjan B.

Int J Clin Pediatr Dent. 2017 Apr-Jun;10(2):172-176. doi: 10.5005/jp-journals-10005-1429. Epub 2017 Jun 1.

7.

Biodentine-A New Novel Bio-Inductive Material For Treatment of Traumatically Injured Tooth (Single Visit Apexification).

Niranjan B, Shashikiran ND, Dubey A, Singla S, Gupta N.

J Clin Diagn Res. 2016 Sep;10(9):ZJ03-ZJ04. Epub 2016 Sep 1. No abstract available.

8.

A comparative microleakage evaluation of three different base materials in Class I cavity in deciduous molars in sandwich technique using dye penetration and dentin surface interface by scanning electron microscope.

Niranjan B, Shashikiran ND, Singla S, Thakur R, Dubey A, Maran S.

J Indian Soc Pedod Prev Dent. 2016 Oct-Dec;34(4):324-30. doi: 10.4103/0970-4388.191410.

9.

Synthesis and preliminary investigations into novel 1,2,3-triazole-derived androgen receptor antagonists inspired by bicalutamide.

Altimari JM, Niranjan B, Risbridger GP, Schweiker SS, Lohning AE, Henderson LC.

Bioorg Med Chem Lett. 2014 Nov 1;24(21):4948-53. doi: 10.1016/j.bmcl.2014.09.036. Epub 2014 Sep 19.

PMID:
25301770
10.

Non-hereditary cherubism.

Niranjan B, Shashikiran N, Singla S, Kasetty S.

J Oral Maxillofac Pathol. 2014 Jan;18(1):84-8. doi: 10.4103/0973-029X.131920.

11.

Preliminary investigations into triazole derived androgen receptor antagonists.

Altimari JM, Niranjan B, Risbridger GP, Schweiker SS, Lohning AE, Henderson LC.

Bioorg Med Chem. 2014 May 1;22(9):2692-706. doi: 10.1016/j.bmc.2014.03.018. Epub 2014 Apr 1.

PMID:
24726305
12.

Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer.

McGrath MJ, Binge LC, Sriratana A, Wang H, Robinson PA, Pook D, Fedele CG, Brown S, Dyson JM, Cottle DL, Cowling BS, Niranjan B, Risbridger GP, Mitchell CA.

Cancer Res. 2013 Aug 15;73(16):5066-79. doi: 10.1158/0008-5472.CAN-12-4520. Epub 2013 Jun 25.

13.

A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer.

Clark AK, Taubenberger AV, Taylor RA, Niranjan B, Chea ZY, Zotenko E, Sieh S, Pedersen JS, Norden S, Frydenberg M, Grummet JP, Pook DW; Australian Prostate Cancer BioResource, Stirzaker C, Clark SJ, Lawrence MG, Ellem SJ, Hutmacher DW, Risbridger GP.

Biomaterials. 2013 Jul;34(20):4777-85. doi: 10.1016/j.biomaterials.2013.03.005. Epub 2013 Apr 2.

PMID:
23562048
14.

A preclinical xenograft model of prostate cancer using human tumors.

Lawrence MG, Taylor RA, Toivanen R, Pedersen J, Norden S, Pook DW, Frydenberg M; Australian Prostate Cancer BioResource, Papargiris MM, Niranjan B, Richards MG, Wang H, Collins AT, Maitland NJ, Risbridger GP.

Nat Protoc. 2013 May;8(5):836-48. doi: 10.1038/nprot.2013.043. Epub 2013 Apr 4.

PMID:
23558784
15.

Primary culture and propagation of human prostate epithelial cells.

Niranjan B, Lawrence MG, Papargiris MM, Richards MG, Hussain S, Frydenberg M, Pedersen J, Taylor RA, Risbridger GP.

Methods Mol Biol. 2013;945:365-82. doi: 10.1007/978-1-62703-125-7_22.

PMID:
23097118
16.

Unilateral pulmonary agenesis-a rare cause of respiratory distress in infancy.

Shrikhande D, Singh G, Kunal A, Niranjan B, Kumar CA.

Med J Armed Forces India. 2012 Apr;68(2):176-8. doi: 10.1016/S0377-1237(12)60026-4. Epub 2012 Apr 21. No abstract available.

17.

A comparative assessment of α-lipoic acid N-phenylamides as non-steroidal androgen receptor antagonists both on and off gold nanoparticles.

Henderson LC, Altimari JM, Dyson G, Servinis L, Niranjan B, Risbridger GP.

Bioorg Chem. 2012 Feb;40(1):1-5. doi: 10.1016/j.bioorg.2011.11.007. Epub 2011 Dec 8.

PMID:
22196975
18.

Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated.

McPherson SJ, Hussain S, Balanathan P, Hedwards SL, Niranjan B, Grant M, Chandrasiri UP, Toivanen R, Wang Y, Taylor RA, Risbridger GP.

Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3123-8. doi: 10.1073/pnas.0905524107. Epub 2010 Feb 1.

19.

Activin C antagonizes activin A in vitro and overexpression leads to pathologies in vivo.

Gold E, Jetly N, O'Bryan MK, Meachem S, Srinivasan D, Behuria S, Sanchez-Partida LG, Woodruff T, Hedwards S, Wang H, McDougall H, Casey V, Niranjan B, Patella S, Risbridger G.

Am J Pathol. 2009 Jan;174(1):184-95. doi: 10.2353/ajpath.2009.080296. Epub 2008 Dec 18.

20.

Characterization of gametogenetin 1 (GGN1) and its potential role in male fertility through the interaction with the ion channel regulator, cysteine-rich secretory protein 2 (CRISP2) in the sperm tail.

Jamsai D, Bianco DM, Smith SJ, Merriner DJ, Ly-Huynh JD, Herlihy A, Niranjan B, Gibbs GM, O'Bryan MK.

Reproduction. 2008 Jun;135(6):751-9. doi: 10.1530/REP-07-0485.

PMID:
18502891
21.
22.

A comparative study of modified radical mastectomy using harmonic scalpel and electrocautery.

Deo SV, Shukla NK, Asthana S, Niranjan B, Srinivas G.

Singapore Med J. 2002 May;43(5):226-8.

PMID:
12188072
23.

Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation.

Evron E, Umbricht CB, Korz D, Raman V, Loeb DM, Niranjan B, Buluwela L, Weitzman SA, Marks J, Sukumar S.

Cancer Res. 2001 Mar 15;61(6):2782-7.

24.

Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation.

Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, Weitzman SA, Korz D, Sukumar S.

Cancer Res. 2001 Feb 1;61(3):921-5.

25.

Symptomatic outcome after laparoscopic cholecystectomy.

Niranjan B, Chumber S, Kriplani AK.

Trop Gastroenterol. 2000 Jul-Sep;21(3):144-8.

PMID:
11084841
26.

HGF/SF in mammary epithelial growth and morphogenesis: in vitro and in vivo models.

Kamalati T, Niranjan B, Yant J, Buluwela L.

J Mammary Gland Biol Neoplasia. 1999 Jan;4(1):69-77. Review.

PMID:
10219907
27.

In vivo effects of hepatocyte growth factor/scatter factor on mouse mammary gland development.

Yant J, Buluwela L, Niranjan B, Gusterson B, Kamalati T.

Exp Cell Res. 1998 Jun 15;241(2):476-81.

PMID:
9637789
28.

Inhibitory effects of activin on the growth and morpholgenesis of primary and transformed mammary epithelial cells.

Liu QY, Niranjan B, Gomes P, Gomm JJ, Davies D, Coombes RC, Buluwela L.

Cancer Res. 1996 Mar 1;56(5):1155-63.

29.

Differentiation antigens in stromal and epithelial cells of the breast.

Kamalati T, Niranjan B, Atherton A, Anbazhaghan R, Gusterson B.

Cancer Treat Res. 1996;83:227-42. Review. No abstract available.

PMID:
8826650
30.

HGF/SF: a potent cytokine for mammary growth, morphogenesis and development.

Niranjan B, Buluwela L, Yant J, Perusinghe N, Atherton A, Phippard D, Dale T, Gusterson B, Kamalati T.

Development. 1995 Sep;121(9):2897-908.

31.
32.

Stimulation of transcription and translation by aurin tricarboxylic acid in mitochondrial lysates from Ehrlich ascites cells.

Kulkarni GR, Kantharaj GR, Fluellen C, Niranjan BG, Avadhani NG.

Biochem Biophys Res Commun. 1987 Jun 30;145(3):1149-57.

PMID:
3606599
33.

Protection of mitochondrial genetic system against aflatoxin B1 binding in animals resistant to aflatoxicosis.

Niranjan BG, Schaefer H, Ritter C, Avadhani NG.

Cancer Res. 1986 Jul;46(7):3637-41.

34.

Formation of benzo(alpha)pyrene metabolites and DNA adducts catalyzed by a rat liver mitochondrial monooxygenase system.

Niranjan BG, Avadhani NG, DiGiovanni J.

Biochem Biophys Res Commun. 1985 Sep 16;131(2):935-42.

PMID:
2996532
35.
36.

Preparation of 6-aminopenicillanic acid--chemical vs enzymatic methods.

Bhattacharyya PK, Niranjan BG, Jacob JN, Nataraj CV, Bhatnagar SP, Iyengar RR, Venkataram UV, Manivel V.

Hindustan Antibiot Bull. 1982 Aug-Nov;24(3-4):108-18. No abstract available.

PMID:
6302033
37.

Qualitative and comparative nature of mitochondrial translation products in mammalian cells.

Bhat NK, Niranjan BG, Avadhani NG.

Biochemistry. 1982 May 11;21(10):2452-60.

PMID:
7093198
38.

Inhibition of mitochondrial protein synthesis during early stages of aflatoxin B1-induced hepatocarcinogenesis.

Bhat NK, Emeh JK, Niranjan BG, Avadhani NG.

Cancer Res. 1982 May;42(5):1876-80.

39.

Preferential attack of mitochondrial DNA by aflatoxin B1 during hepatocarcinogenesis.

Niranjan BG, Bhat NK, Avadhani NG.

Science. 1982 Jan 1;215(4528):73-5.

PMID:
6797067
40.

The complexity of mitochondrial translation products in mammalian cells.

Bhat NK, Niranjan BG, Avadhani NG.

Biochem Biophys Res Commun. 1981 Nov 30;103(2):621-8. No abstract available.

PMID:
7332559
41.

Modulation of hepatic transcription and translation during early stages of aflatoxin B1 carcinogenesis.

Emeh JK, Niranjan BG, Bhat NK, Avadhani NG.

Carcinogenesis. 1981;2(5):373-8.

PMID:
6168408
42.

Polysome-dependent in vitro translation system capable of peptide chain reinitiation.

Aroskar VA, Watt RA, Emeh JK, Niranjan BG, Biunno I, Avadhani NG.

Biochemistry. 1980 Dec 23;19(26):6105-11.

PMID:
7470453
43.

Activation of aflatoxin B1 by a mono-oxygenase system localized in rat liver mitochondria.

Niranjan BG, Avadhani NG.

J Biol Chem. 1980 Jul 25;255(14):6575-8.

44.

Tissue specificity of mitochondrial monooxygenase system for aflatoxin B1 activation.

Niranjan BG, Avadhani NG.

Biochem Biophys Res Commun. 1980 Jun 16;94(3):1021-6. No abstract available.

PMID:
6156679
45.

Phenomenological and basic studies with affinity systems.

Bhattacharyya PK, Nataraj CV, Sreenivasan Y, Niranjan BG, Jacob JN.

Hindustan Antibiot Bull. 1978 Feb-May;20(3-4):92-8. No abstract available.

PMID:
748292

Supplemental Content

Loading ...
Support Center